 Marc Mathias
Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macular Degeneration | 12 | 2023 | 152 | 2.050 |
Why?
| | Geographic Atrophy | 6 | 2023 | 49 | 1.090 |
Why?
| | Visual Acuity | 8 | 2023 | 274 | 0.600 |
Why?
| | Retinal Drusen | 3 | 2021 | 25 | 0.550 |
Why?
| | Eye Infections, Bacterial | 2 | 2015 | 26 | 0.520 |
Why?
| | Wet Macular Degeneration | 3 | 2020 | 32 | 0.500 |
Why?
| | Orbital Cellulitis | 1 | 2012 | 14 | 0.400 |
Why?
| | Endophthalmitis | 3 | 2017 | 25 | 0.380 |
Why?
| | Complement Factor B | 2 | 2022 | 100 | 0.340 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2012 | 191 | 0.330 |
Why?
| | Registries | 4 | 2020 | 1760 | 0.320 |
Why?
| | Staphylococcal Infections | 1 | 2012 | 336 | 0.300 |
Why?
| | Choroid Diseases | 2 | 2023 | 9 | 0.260 |
Why?
| | Chemokine CCL5 | 2 | 2023 | 45 | 0.250 |
Why?
| | Vitreous Body | 2 | 2015 | 101 | 0.230 |
Why?
| | Retinal Degeneration | 1 | 2023 | 30 | 0.220 |
Why?
| | Tomography, Optical Coherence | 3 | 2022 | 130 | 0.200 |
Why?
| | Fluorescein Angiography | 4 | 2023 | 102 | 0.190 |
Why?
| | National Eye Institute (U.S.) | 1 | 2020 | 6 | 0.190 |
Why?
| | Neurodegenerative Diseases | 1 | 2022 | 91 | 0.180 |
Why?
| | Retinal Neovascularization | 1 | 2019 | 20 | 0.170 |
Why?
| | Complement Membrane Attack Complex | 1 | 2019 | 33 | 0.160 |
Why?
| | Complement C3a | 1 | 2019 | 33 | 0.160 |
Why?
| | Estrogen Replacement Therapy | 1 | 2019 | 116 | 0.160 |
Why?
| | Choroidal Neovascularization | 1 | 2019 | 44 | 0.160 |
Why?
| | Internet | 1 | 2023 | 599 | 0.160 |
Why?
| | Vitrectomy | 2 | 2015 | 57 | 0.140 |
Why?
| | Anterior Eye Segment | 1 | 2017 | 9 | 0.140 |
Why?
| | Strabismus | 1 | 2017 | 26 | 0.140 |
Why?
| | Automobile Driving | 1 | 2018 | 128 | 0.140 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2017 | 57 | 0.140 |
Why?
| | Complement Activation | 1 | 2019 | 340 | 0.140 |
Why?
| | Retinal Vein Occlusion | 1 | 2015 | 13 | 0.120 |
Why?
| | Needles | 1 | 2015 | 51 | 0.120 |
Why?
| | Surveys and Questionnaires | 3 | 2022 | 4635 | 0.120 |
Why?
| | Biopsy, Needle | 1 | 2015 | 183 | 0.120 |
Why?
| | Self Report | 1 | 2018 | 696 | 0.120 |
Why?
| | Aged | 10 | 2022 | 19122 | 0.120 |
Why?
| | Fibrin | 1 | 2014 | 65 | 0.110 |
Why?
| | Ischemia | 1 | 2017 | 362 | 0.110 |
Why?
| | Humans | 21 | 2023 | 114937 | 0.110 |
Why?
| | Angiogenesis Inhibitors | 1 | 2015 | 215 | 0.110 |
Why?
| | Research Design | 1 | 2019 | 932 | 0.110 |
Why?
| | Female | 14 | 2023 | 59581 | 0.110 |
Why?
| | Retina | 1 | 2015 | 263 | 0.100 |
Why?
| | Diabetic Retinopathy | 1 | 2014 | 149 | 0.100 |
Why?
| | Aged, 80 and over | 5 | 2021 | 6364 | 0.100 |
Why?
| | Ocular Motility Disorders | 1 | 2012 | 25 | 0.100 |
Why?
| | Eyelid Diseases | 1 | 2012 | 21 | 0.100 |
Why?
| | Biomarkers | 4 | 2023 | 3418 | 0.100 |
Why?
| | Edema | 1 | 2012 | 119 | 0.090 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2015 | 666 | 0.090 |
Why?
| | Male | 11 | 2023 | 55663 | 0.090 |
Why?
| | Atrophy | 2 | 2023 | 151 | 0.080 |
Why?
| | Bacteria | 1 | 2015 | 728 | 0.080 |
Why?
| | Retrospective Studies | 5 | 2023 | 12544 | 0.080 |
Why?
| | Choroid | 2 | 2021 | 47 | 0.080 |
Why?
| | Quality of Life | 3 | 2022 | 2359 | 0.070 |
Why?
| | Middle Aged | 6 | 2019 | 26806 | 0.070 |
Why?
| | Anti-Bacterial Agents | 2 | 2015 | 1477 | 0.070 |
Why?
| | Colorado | 3 | 2022 | 4091 | 0.070 |
Why?
| | Odds Ratio | 2 | 2019 | 954 | 0.070 |
Why?
| | Follow-Up Studies | 3 | 2020 | 4427 | 0.060 |
Why?
| | Postoperative Complications | 1 | 2014 | 2133 | 0.060 |
Why?
| | Phenotype | 2 | 2022 | 2817 | 0.050 |
Why?
| | Interleukin-4 | 1 | 2023 | 208 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2012 | 2326 | 0.050 |
Why?
| | Complement Factor I | 1 | 2022 | 12 | 0.050 |
Why?
| | Inflammation | 2 | 2023 | 2485 | 0.050 |
Why?
| | Retinal Ganglion Cells | 1 | 2022 | 92 | 0.050 |
Why?
| | Vision Disorders | 1 | 2022 | 130 | 0.050 |
Why?
| | Fibrinogen | 1 | 2022 | 154 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 1 | 2012 | 3053 | 0.050 |
Why?
| | Sickness Impact Profile | 1 | 2020 | 50 | 0.050 |
Why?
| | Immunologic Factors | 1 | 2022 | 221 | 0.040 |
Why?
| | Protective Factors | 1 | 2019 | 87 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2020 | 4407 | 0.040 |
Why?
| | C-Reactive Protein | 1 | 2021 | 362 | 0.040 |
Why?
| | Infant | 1 | 2012 | 7937 | 0.040 |
Why?
| | Prospective Studies | 2 | 2020 | 6218 | 0.040 |
Why?
| | Child, Preschool | 1 | 2012 | 9086 | 0.040 |
Why?
| | Anti-Inflammatory Agents | 1 | 2021 | 451 | 0.040 |
Why?
| | Iris Diseases | 1 | 2017 | 5 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2022 | 635 | 0.040 |
Why?
| | Mental Health | 1 | 2022 | 559 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 797 | 0.040 |
Why?
| | Young Adult | 1 | 2012 | 10478 | 0.030 |
Why?
| | Microbiological Techniques | 1 | 2015 | 29 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2015 | 111 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2019 | 1440 | 0.030 |
Why?
| | Intravitreal Injections | 1 | 2015 | 45 | 0.030 |
Why?
| | Logistic Models | 1 | 2019 | 1844 | 0.030 |
Why?
| | Macular Edema | 1 | 2015 | 34 | 0.030 |
Why?
| | Proteomics | 1 | 2020 | 844 | 0.030 |
Why?
| | Bevacizumab | 1 | 2015 | 115 | 0.030 |
Why?
| | Adult | 2 | 2015 | 30608 | 0.030 |
Why?
| | Proteins | 1 | 2020 | 912 | 0.030 |
Why?
| | T-Lymphocytes | 1 | 2022 | 1749 | 0.030 |
Why?
| | Adolescent | 1 | 2012 | 17829 | 0.030 |
Why?
| | Child | 1 | 2012 | 18366 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2019 | 3008 | 0.030 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2015 | 499 | 0.030 |
Why?
| | Time Factors | 1 | 2020 | 6125 | 0.020 |
Why?
| | Cohort Studies | 1 | 2019 | 4903 | 0.020 |
Why?
| | Models, Biological | 1 | 2015 | 1630 | 0.020 |
Why?
| | Risk Factors | 1 | 2019 | 8637 | 0.020 |
Why?
| | United States | 1 | 2020 | 12211 | 0.010 |
Why?
|
|
Mathias's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|